Cargando…

Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells

BACKGROUND: Multiple myeloma (MM) cells gain protection against drugs through interaction with bone marrow stromal cells (BMSCs). This form of resistance largely accounts for resistance to therapy in MM patients which warrants further exploration to identify more potential therapeutic targets. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdi, Jahangir, Rastgoo, Nasrin, Chen, Yan, Chen, Guo An, Chang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805455/ https://www.ncbi.nlm.nih.gov/pubmed/31638931 http://dx.doi.org/10.1186/s12885-019-6151-x

Ejemplares similares

Role of epigenetics-microRNA axis in drug resistance of multiple myeloma
por: Rastgoo, Nasrin, et al.
Publicado: (2017)

Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis
por: Abdi, Jahangir, et al.
Publicado: (2017)

miR-101-3p sensitizes lung adenocarcinoma cells to irradiation via targeting BIRC5
por: Meng, Xin, et al.
Publicado: (2021)

Targeting CD47/TNFAIP8 by miR-155 overcomes drug resistance and inhibits tumor growth through induction of phagocytosis and apoptosis in multiple myeloma
por: Rastgoo, Nasrin, et al.
Publicado: (2019)

Micro-RNAs, New performers in multiple myeloma bone marrow microenvironment
por: Abdi, Jahangir, et al.
Publicado: (2014)

Bone Marrow Stroma-Induced Transcriptome and Regulome Signatures of Multiple Myeloma
por: Dziadowicz, Sebastian A., et al.
Publicado: (2022)

miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5
por: Yuan, Chao, et al.
Publicado: (2021)

The Effect of Belantamab Mafodotin on Primary Myeloma–Stroma Co-Cultures: Asymmetrical Mitochondrial Transfer between Myeloma Cells and Autologous Bone Marrow Stromal Cells
por: Matula, Zsolt, et al.
Publicado: (2023)

Toll-Like Receptor (TLR)-1/2 Triggering of Multiple Myeloma Cells Modulates Their Adhesion to Bone Marrow Stromal Cells and Enhances Bortezomib-Induced Apoptosis
por: Abdi, Jahangir, et al.
Publicado: (2014)

lncRNA SNHG1 attenuates osteogenic differentiation via the miR-101/DKK1 axis in bone marrow mesenchymal stem cells
por: Xiang, Jie, et al.
Publicado: (2020)

BIRC3 and BIRC5: multi‐faceted inhibitors in cancer
por: Frazzi, Raffaele
Publicado: (2021)

miRNA-101 promotes chondrogenic differentiation in rat bone marrow mesenchymal stem cells
por: Gao, Feng, et al.
Publicado: (2019)

MiR-101 Targets the EZH2/Wnt/β-Catenin the Pathway to Promote the Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells
por: Wang, Hongrui, et al.
Publicado: (2016)

OP9 Bone Marrow Stroma Cells Differentiate into Megakaryocytes and Platelets
por: Matsubara, Yumiko, et al.
Publicado: (2013)

Inflammation as a Keystone of Bone Marrow Stroma Alterations in Primary Myelofibrosis
por: Desterke, Christophe, et al.
Publicado: (2015)

Resistance of bone marrow stroma to genotoxic preconditioning is determined by p53
por: Fedtsova, Natalia, et al.
Publicado: (2021)

Repression of Mcl-1 expression by the CDC7/CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML
por: O’ Reilly, Eimear, et al.
Publicado: (2018)

miR‐92a‐3p promotes breast cancer proliferation by regulating the KLF2/BIRC5 axis
por: Yu, Zhi‐Hao, et al.
Publicado: (2022)

Stroma-derived miR-214 coordinates tumor dissemination
por: Orso, Francesca, et al.
Publicado: (2023)

miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway
por: Wang, Baojin, et al.
Publicado: (2018)

The miR-195 Axis Regulates Chemoresistance through TUBB and Lung Cancer Progression through BIRC5
por: Yu, Xiaojie, et al.
Publicado: (2019)

Bone Marrow-Derived Cells Contribute to the Maintenance of Thymic Stroma including TECs
por: Chakrabarti, Shami, et al.
Publicado: (2022)

Arachnoid granulations are lymphatic conduits that communicate with bone marrow and dura-arachnoid stroma
por: Shah, Trishna, et al.
Publicado: (2022)

Osteolytic cancer cells induce vascular/axon guidance processes in the bone/bone marrow stroma
por: Hensel, Janine, et al.
Publicado: (2018)

MiR-204 acts as a potential therapeutic target in acute myeloid leukemia by increasing BIRC6-mediated apoptosis
por: Wang, Zhiguo, et al.
Publicado: (2018)

PTBP1 enhances miR-101-guided AGO2 targeting to MCL1 and promotes miR-101-induced apoptosis
por: Cui, Jia, et al.
Publicado: (2018)

Diagnostic and prognostic implications of serum miR-101 in osteosarcoma
por: Yao, Z.-S., et al.
Publicado: (2018)

Paclitaxel Suppresses Hepatocellular Carcinoma Tumorigenesis Through Regulating Circ-BIRC6/miR-877-5p/YWHAZ Axis
por: Liu, Yi, et al.
Publicado: (2020)

EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
por: Tremblay-LeMay, Rosemarie, et al.
Publicado: (2018)

MiR-101 and miR-144 Regulate the Expression of the CFTR Chloride Channel in the Lung
por: Hassan, Fatemat, et al.
Publicado: (2012)

Expression and significance of miR-24 and miR-101 in patients with advanced gastric cancer
por: Dong, Xuetao, et al.
Publicado: (2018)

Origins of the Tumor Microenvironment: Quantitative Assessment of Adipose-Derived and Bone Marrow–Derived Stroma
por: Kidd, Shannon, et al.
Publicado: (2012)

Impaired Endothelial Progenitor Cell Mobilization and Dysfunctional Bone Marrow Stroma in Diabetes Mellitus
por: Westerweel, Peter E., et al.
Publicado: (2013)

Osterix-Cre Labeled Progenitor Cells Contribute to the Formation and Maintenance of the Bone Marrow Stroma
por: Liu, Yaling, et al.
Publicado: (2013)

The bone marrow stroma in human myelodysplastic syndrome reveals alterations that regulate disease progression
por: Kfoury, Youmna S., et al.
Publicado: (2023)

P1329: REGIONAL COMPARTMENTALIZATION OF THE BONE MARROW STROMA IS IMPORTANT FOR RESPONSES TO INFLAMMATION AND CANCER
por: Swann, James, et al.
Publicado: (2023)

Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms
por: Abdi, Jahangir, et al.
Publicado: (2013)

Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms
por: Abdi, Jahangir, et al.
Publicado: (2013)

miR‐126‐5p enhances radiosensitivity of lung adenocarcinoma cells by inhibiting EZH2 via the KLF2/BIRC axis
por: Han, Fushi, et al.
Publicado: (2022)

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
por: Tremblay-LeMay, Rosemarie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ik2ce3kmkf0klmc444e4nrmnq7